Sort
30,917 grants matching “tumor microenvironment”
Analysis of the Role of Microenvironment and Stem Cells in Initiation, Progressio
$357,363Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2010 · CA
Bioengineering 3-D Models for Breast Cancer Therapy
$357,363Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2010 · CA
Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
$357,342Owen N Witte · University Of California Los Angeles · P50 · FY2019 · CA
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$357,337David G Denardo · Washington University · P50 · FY2016 · CA
RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia
$357,329Brent H. Cochran · Tufts University Boston · R01 · FY2014 · NS
Project 1: Employing CD11b-Agonists to Render PDAC Responsive to Immunotherapy
$357,273David G Denardo · Washington University · P50 · FY2023 · CA
Microfluidic platform for tumor cell invasion
$357,239Mingming Wu · Cornell University · R01 · FY2019 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$357,238Edmund K. Moon · University Of Pennsylvania · R01 · FY2019 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$357,238Gregory L Beatty · University Of Pennsylvania · R01 · FY2019 · CA
Immunologic aspects of targeted therapy of erbB tumors
$357,238Mark I Greene · University Of Pennsylvania · R01 · FY2019 · CA
METEOR Administrative Core
$357,233Clifford Grant Robinson · Washington University · U54 · FY2024 · CA
Clinical specimen tumor-TME acquired resistance
$357,227Trever G Bivona · University Of California, San Francisco · U54 · FY2022 · CA
Local Tumoral Delivered Immune Checkpoint Blockades Immunotherapy and Radioembolization Combination Therapy
$357,212Dong-Hyun Kim · Northwestern University At Chicago · R01 · FY2023 · CA
Transcatheter Intra-Arterial Delivery of Oriented Anti-PD-L1 Immune checkpoint inhibitors Immobilized Nanocarriers for Local Combination Immunotherapy of Hepatocellular Carcinoma
$357,212Dong-Hyun Kim · Northwestern University At Chicago · R01 · FY2024 · CA
UCLA Tumor Immunology Institutional Training Grant
$357,202Michael A Teitell · University Of California Los Angeles · T32 · FY2024 · CA
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS
$357,176Sheila A Stewart · Washington University · R01 · FY2021 · CA
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS
$357,176Sheila A Stewart · Washington University · R01 · FY2020 · CA
SENESCENT STROMA STIMULATES INFLAMMATION TO PROMOTE TUMORIGENESIS
$357,176Sheila A Stewart · Washington University · R01 · FY2018 · CA
Transcriptional mechanisms and melanoma
$357,175Leonard I Zon · Massachusetts General Hospital · P01 · FY2022 · CA
Transcriptional mechanisms and melanoma
$357,170Leonard I Zon · Massachusetts General Hospital · P01 · FY2023 · CA
Transformative lightsheet microscopy techniques for subcellular imaging in physiologically relevant 3D environments
$357,154Tonmoy Chakraborty · University Of New Mexico · R35 · FY2023 · GM
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
$357,100Bing Xu · Brandeis University · R01 · FY2019 · CA
Hepatic stellate cell regulation of metastatic growth in the liver
$357,081Ningling Kang · University Of Minnesota · R01 · FY2019 · CA
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
$357,068Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2020 · CA
Determine the Functional Role Dub3 in Breast Cancer Progression and Metastasis
$357,064Binhua P Zhou · University Of Kentucky · R01 · FY2015 · CA